Shizuoka, Japan

Hirohiko Shimizu

This inventor holds 1 USPTO granted patent, plus 2 CIPO patents. Top assignee: Nrl Pharma, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hirohiko Shimizu. Retrieved from https://idiyas.com/inventor/hirohiko-shimizu-422jo5hl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hirohiko Shimizu: Innovator in Pharmaceutical Composition

Introduction

Hirohiko Shimizu is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at alleviating pain and anxiety in patients.

Latest Patents

Shimizu holds a patent for a novel pharmaceutical composition that utilizes lactoferrin as an active ingredient. This innovative composition is designed to address various conditions, including pain and anxiety, which can severely impact the quality of life for patients, especially those suffering from end-stage cancer. The composition is also effective in treating pain associated with arthritis and other joint-related diseases.

Career Highlights

Hirohiko Shimizu is currently associated with Nrl Pharma, Inc., where he continues to advance his research and development efforts. His work focuses on creating effective solutions for pain management and anxiety relief, contributing to the well-being of patients.

Collaborations

Shimizu collaborates with esteemed colleagues, including Etsumori Harada and Takashi Takeuchi, to further enhance the impact of his inventions in the pharmaceutical industry.

Conclusion

Hirohiko Shimizu's innovative work in pharmaceutical compositions demonstrates his commitment to improving patient care and quality of life. His contributions are invaluable in the ongoing quest for effective treatments for pain and anxiety.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…